Investigation of how sex steroids and nicotinic acetylcholine receptors promote cocaine self-administration

NIH RePORTER · NIH · K00 · $80,913 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT About 12 million individuals over the age of 12 have a substance use disorder (SUD). Cocaine is involved in about 1 in 5 overdoses in the United States and is abused by both men and women. Women are more vulnerable to the rewarding effects of cocaine and more rapidly progress from initial use to dependence than men but the neurobiological mechanisms that contribute to these differences are yet to be determined. A limitation of the current work investigating sex differences in preclinical research is that the research is primarily focused on hormonal contributions that may be driving sex differences. There is little understanding of how sex steroids and other neurobiological mechanisms contribute to cocaine dependence. The overall goal of this project is to identify the effects of a history of cocaine self-administration on sex steroids and nicotinic acetylcholine receptor (nAChRs) subunit expression and to test the hypothesis that decreased nAChRs alpha 5 (ɑ5) in the dorsal hippocampus (dHIPP) produced by decreased progesterone levels promote cocaine self-administration behavior. Aim 1 will use single-cell transcriptomics to identify sex differences in the dysregulated transcriptional networks in rats with a history of compulsive-like cocaine self-administration using brain (dHIPP), adrenal, pituitary, reproductive organ samples. Aim 2 will causally investigate the role of the nAChR ɑ5 in the dHIPP and progesterone on cocaine self-administration behavior using an AAV-ShRNA to knock down nAChRs ɑ5 in the dHIPP and pharmacology to block the progesterone receptor. These projects will be the first to look at associations between sex steroids and nAChR ɑ5 in the dHIPP on cocaine selfadministration in both sexes. My Sponsor, Dr. Olivier George (UCSD) is an expert on the neurobiology of drugs of abuse and addiction and is recognized as an innovative leader in the field of drug abuse and, therefore, the perfect fit to mentor me for the proposed research. The proposed Research and Training Plans will deepen my knowledge of transcriptomics, the cholinergic system, the hippocampus, and neuroendocrinology in addictionlike phenotypes and will expand my expertise in cocaine dependency. The training I will receive in single-cell transcriptomics, ELISAs, bioinformatics, intrajugular catheter surgeries, and advanced operant paradigms will give me the skills necessary to answer questions focused on cell-specific differences in males and females that may be driving dysregulation of reward circuitry pre- and post-drug exposure. The training I have received in the F99 phase and the training I will receive in the K00 phase will allow me to establish a lab where I can research my long-term research goal of investigating the mechanisms underlying maladaptive addiction behaviors and how these behaviors differentiate by sex.

Key facts

NIH application ID
10625154
Project number
8K00DA057923-03
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Principal Investigator
Elizabeth Sneddon
Activity code
K00
Funding institute
NIH
Fiscal year
2023
Award amount
$80,913
Award type
8
Project period
2020-12-01 → 2027-01-31